Loading…

presence of the top prescribed pharmaceuticals in treated sewage effluents and receiving waters in Southwest Nova Scotia, Canada

From a list of the top prescribed drugs in Canada, 11 pharmaceuticals and two metabolites were selected for study in municipal sewage treatment plant effluents and receiving waters. Wastewater samples were collected from 16 wastewater treatment plants across Southwest Nova Scotia including the Annap...

Full description

Saved in:
Bibliographic Details
Published in:Environmental science and pollution research international 2015-01, Vol.22 (1), p.689-700
Main Authors: Ghoshdastidar, Avik J, Fox, Shannon, Tong, Anthony Z
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:From a list of the top prescribed drugs in Canada, 11 pharmaceuticals and two metabolites were selected for study in municipal sewage treatment plant effluents and receiving waters. Wastewater samples were collected from 16 wastewater treatment plants across Southwest Nova Scotia including the Annapolis Valley, South Shore, and Metropolitan Halifax. Samples were also collected between 100 and 200 m downstream of effluent outflows. Seven pharmaceuticals were found above μg/L levels with their highest concentrations as follows: metformin (10.6 μg/L), acetaminophen (28.9 μg/L), paraxanthine (18.2 μg/L), cotinine (3.10 μg/L), caffeine (115 μg/L), naproxen (29.1 μg/L), and venlafaxine (2.65 μg/L). Metformin, paraxanthine, caffeine, naproxen, ramipril, and venlafaxine were detected in every wastewater effluent sample. Statistical analysis revealed significant differences in pharmaceutical occurrence by treatment methods, weak dependence of pharmaceutical concentrations on populations, and the co-occurrence of some pharmaceuticals. Experimental results might indicate the limitation of primary only treatment methods in breaking down pharmaceuticals.
ISSN:0944-1344
1614-7499
DOI:10.1007/s11356-014-3400-z